LONDON (AP) -- Experts at the agency that regulates drugs for the European Union say they found a "possible link" between the Johnson & Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the United States.
But they say the vaccine's benefits still outweigh the very small risks of recipients developing the unusual clots.
The European Medicines Agency said Tuesday that a warning about blood clots should be added to labels for Johnson & Johnson's vaccine. The agency said these rare blood disorders should be considered as "very rare side effects of the vaccine."
Last week, Johnson & Johnson halted the European roll-out of its vaccine.